JPWO2021138419A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021138419A5 JPWO2021138419A5 JP2022540327A JP2022540327A JPWO2021138419A5 JP WO2021138419 A5 JPWO2021138419 A5 JP WO2021138419A5 JP 2022540327 A JP2022540327 A JP 2022540327A JP 2022540327 A JP2022540327 A JP 2022540327A JP WO2021138419 A5 JPWO2021138419 A5 JP WO2021138419A5
- Authority
- JP
- Japan
- Prior art keywords
- independently selected
- alkyl
- group
- optionally substituted
- ring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962955853P | 2019-12-31 | 2019-12-31 | |
| US62/955,853 | 2019-12-31 | ||
| US202063090547P | 2020-10-12 | 2020-10-12 | |
| US63/090,547 | 2020-12-10 | ||
| PCT/US2020/067463 WO2021138419A1 (en) | 2019-12-31 | 2020-12-30 | Compounds and compositions for treating conditions associated with sting activity |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023509421A JP2023509421A (ja) | 2023-03-08 |
| JP2023509421A5 JP2023509421A5 (https=) | 2025-06-25 |
| JPWO2021138419A5 true JPWO2021138419A5 (https=) | 2025-06-25 |
Family
ID=74550729
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022540327A Revoked JP2023509421A (ja) | 2019-12-31 | 2020-12-30 | Ｓｔｉｎｇ活性に関連する状態を治療するための化合物および組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230115274A1 (https=) |
| EP (1) | EP4085061A1 (https=) |
| JP (1) | JP2023509421A (https=) |
| CN (1) | CN115279770A (https=) |
| PY (1) | PY2089151A (https=) |
| TW (1) | TW202136255A (https=) |
| UY (1) | UY39005A (https=) |
| WO (1) | WO2021138419A1 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112823036B (zh) | 2018-07-03 | 2024-11-08 | 艾福姆德尤股份有限公司 | 用于治疗与sting活性有关的疾病的化合物和组合物 |
| EP4267129A1 (en) | 2020-12-22 | 2023-11-01 | IFM Due, Inc. | Methods of treating cancer |
| EP4267128A1 (en) | 2020-12-22 | 2023-11-01 | IFM Due, Inc. | Methods of treating cancer |
| WO2022140397A1 (en) | 2020-12-22 | 2022-06-30 | Ifm Due, Inc. | Methods of treating cancer |
| US20240060982A1 (en) | 2020-12-22 | 2024-02-22 | Ifm Due, Inc. | Methods of treating cancer |
| JP2024502470A (ja) * | 2021-01-08 | 2024-01-19 | アイエフエム デュー インコーポレイテッド | Ｓｔｉｎｇ活性に関連する状態を治療するための化合物および組成物 |
| TW202235073A (zh) | 2021-01-08 | 2022-09-16 | 美商Ｉｆｍ Ｄｕｅ有限公司 | 用於治療與sting活性相關的病狀之化合物及組合物 |
| UY39892A (es) | 2021-08-10 | 2023-03-31 | Novartis Pharma Ag | Compuestos y composiciones para tratar afecciones asociadas con la actividad de STING |
| WO2024032597A1 (zh) * | 2022-08-11 | 2024-02-15 | 杭州中美华东制药有限公司 | 具有sting抑制作用的酰胺类化合物及其药物组合物和用途 |
| WO2024064358A1 (en) | 2022-09-23 | 2024-03-28 | Ifm Due, Inc. | Compounds and compositions for treating conditions associated with sting activity |
| AU2023368953A1 (en) * | 2022-10-28 | 2025-03-27 | Boehringer Ingelheim International Gmbh | Heterocyclic compounds as sting antagonists |
| CN117756698A (zh) * | 2022-12-16 | 2024-03-26 | 中国药科大学 | 脲类化合物及其作为sting抑制剂的医药用途 |
| CN116023321B (zh) * | 2022-12-30 | 2024-11-29 | 中国药科大学 | Sting抑制剂前药及其医药用途 |
| WO2025228902A1 (en) | 2024-04-30 | 2025-11-06 | Boehringer Ingelheim International Gmbh | Heterocyclic acids as sting antagonists and the use thereof as medicament |
| WO2025228899A1 (en) | 2024-04-30 | 2025-11-06 | Boehringer Ingelheim International Gmbh | Further heterocyclic compounds as sting antagonists and the use thereof as medicament |
| WO2025228900A1 (en) | 2024-04-30 | 2025-11-06 | Boehringer Ingelheim International Gmbh | Arylamide substituted indazoles and the use thereof as medicament |
| US20250333398A1 (en) | 2024-04-30 | 2025-10-30 | Boehringer Ingelheim International Gmbh | Monoaryl and hetaryl substituted indazoles and benzimidazoles as sting antagonists and the use thereof as medicament |
| WO2025228895A1 (en) | 2024-04-30 | 2025-11-06 | Boehringer Ingelheim International Gmbh | Hetaryl substituted indazoles and benzimidazoles as sting antagonists and the use thereof as medicament |
| WO2025228889A1 (en) | 2024-04-30 | 2025-11-06 | Boehringer Ingelheim International Gmbh | Monoarylic heterocyclic compounds as sting antagonists and the use thereof as medicament |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7927613B2 (en) | 2002-02-15 | 2011-04-19 | University Of South Florida | Pharmaceutical co-crystal compositions |
| WO2006083005A1 (ja) * | 2005-02-03 | 2006-08-10 | Takeda Pharmaceutical Company Limited | 縮合ピリミジン誘導体およびその用途 |
| WO2012062462A1 (en) * | 2010-11-10 | 2012-05-18 | Grünenthal GmbH | Substituted heteroaromatic carboxamide and urea derivatives as vanilloid receptor ligands |
| WO2012075380A1 (en) | 2010-12-03 | 2012-06-07 | The Trustees Of The University Of Pennsylvania | Tip60 inhibitors |
| FR2970967B1 (fr) * | 2011-01-27 | 2013-02-15 | Pf Medicament | Derives de type azaindazole ou diazaindazole comme medicament |
| CN109394752A (zh) | 2013-10-21 | 2019-03-01 | 德雷克塞尔大学 | 治疗慢性乙型肝炎病毒感染的sting激动剂的用途 |
| EP3556362A1 (en) * | 2018-04-16 | 2019-10-23 | Ecole Polytechnique Federale De Lausanne (Epfl) | Sting inhibitors |
| CN112823036B (zh) * | 2018-07-03 | 2024-11-08 | 艾福姆德尤股份有限公司 | 用于治疗与sting活性有关的疾病的化合物和组合物 |
-
2020
- 2020-12-30 EP EP20849007.8A patent/EP4085061A1/en active Pending
- 2020-12-30 CN CN202080097812.6A patent/CN115279770A/zh active Pending
- 2020-12-30 UY UY0001039005A patent/UY39005A/es unknown
- 2020-12-30 JP JP2022540327A patent/JP2023509421A/ja not_active Revoked
- 2020-12-30 PY PY202002089151A patent/PY2089151A/es unknown
- 2020-12-30 WO PCT/US2020/067463 patent/WO2021138419A1/en not_active Ceased
- 2020-12-30 TW TW109146786A patent/TW202136255A/zh unknown
- 2020-12-30 US US17/789,623 patent/US20230115274A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2021138419A5 (https=) | ||
| JP2021529833A5 (https=) | ||
| JPWO2020010092A5 (https=) | ||
| JP6868739B2 (ja) | 抗ｇａｒｐ抗体 | |
| US11072659B2 (en) | Anti-PD-1 antibodies | |
| CN110087680B (zh) | 使用包含btk抑制剂的组合产品治疗癌症 | |
| US20200055935A1 (en) | Anti-TIM-3 Antibodies | |
| AU2017316473B2 (en) | Anti-Tim-3 antibodies | |
| TWI806840B (zh) | 使用包含parp抑制劑的組合產品治療癌症 | |
| WO2017016497A1 (en) | Anti-pd-1 antibodies and uses thereof | |
| JPWO2020010155A5 (https=) | ||
| CN115925939A (zh) | IL2Rβ/通用γ链抗体 | |
| JP2020182492A (ja) | 抗ｃｄ１３７抗体 | |
| JP2021121216A (ja) | Ｐｄ−１に特異的に結合する可能な抗体及びその機能的断片 | |
| JP2019513809A5 (https=) | ||
| JPWO2020106736A5 (https=) | ||
| JP2022526831A (ja) | ヘテロ環式化合物およびその使用 | |
| CN119136840A (zh) | 喜树碱类衍生物及配体-药物偶联物 | |
| CN113943371A (zh) | 一种抗her2/抗pd-l1双功能抗体及其应用 | |
| JPWO2020150439A5 (https=) | ||
| JP2021516251A (ja) | 抗ｐｄ−１抗体との組み合わせのための抗ｃｄ１３７抗体 | |
| JP7059388B2 (ja) | 抗ｐｄ－ｌ１抗体との組み合わせのための抗ｃｄ１３７抗体 | |
| HK40084551A (en) | Il2rbeta/common gamma chain antibodies | |
| JP2026511256A (ja) | 抗イヌｐｄ－ｌ１抗体 | |
| HK40120568B (zh) | 多特异性偶联物及其应用 |